MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities
December 21, 2021 21:00 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its VYRA™ product line by launching its VYRA™ CoV2Flu Rapid Antigen Rapid...
MedMira strengthen its Board with New Appointment
December 17, 2021 07:53 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announced today the appointment of Mr. Thomas Bergmann to the board effective immediately. Mr....
MedMira announces significant debt reduction and additional growth capital
December 14, 2021 20:00 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces a financial package of over $5.23 million to support the Company’s FY2022 corporate...
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
November 30, 2021 22:00 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2021. Profit and Loss...
MedMira Closes New Equity Investment for Future Growth
July 14, 2021 22:30 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, July 14, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) has closed a CAD$ 0.5 million equity investment with a Canadian arm’s length investor. The...
MedMira Reports Third Quarter Results FY2021
June 29, 2021 22:00 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, June 29, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2021. Profit and Loss Highlights ...
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
June 15, 2021 09:03 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, June 15, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2 serology standards testing results. The...
MedMira Reports Second Quarter Results FY2021
March 31, 2021 22:00 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2021. Profit and Loss...
Product and Regulatory Update on MedMira’s COVID-19 Product Family
March 03, 2021 07:28 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, March 03, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines the company’s COVID-19 market and regulatory...
Progress Update on MedMira’s COVID-19 Product Family
January 29, 2021 20:43 ET
|
MedMira Inc.
HALIFAX, Nova Scotia, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a rapid antibody test prototype that detects the presence of the...